Amarin Promotes CFO John Thero to President
Amarin, a clinical-stage biopharmaceutical company, has promoted chief financial officer (CFO) John Thero to president. He had been CFO since November 2009, a role in which he has been responsible for a significant portion of the company’s operations.
Thero has more than 20 years of senior management experience, including broad responsibilities in finance, business development and commercial operations. Prior to joining Amarin, Thero was CFO at ViaCell, where he helped guide the company to its successful sale, and Abiomed, during its transition from a development-stage company into a commercial entity.
In addition, Frederick Ahlholm, vice president finance, will be principal accounting officer. Ahlholm joined Amarin in March 2010 and has approximately 20 years of financial and management experience at public and private companies. He began his professional career at Ernst & Young and is a certified public accountant (CPA).